|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Trade and other receivables, net of allowances of $3.7 million and $3.9 million as of March 31, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Noncurrent assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Goodwill, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Right-of-use lease assets | ||||||||||||||||||||
| Other noncurrent assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders' Equity (Deficit) | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable and other current liabilities | ||||||||||||||||||||
| Income tax payable | ||||||||||||||||||||
| Cancelled event liabilities | ||||||||||||||||||||
| Deferred revenues | ||||||||||||||||||||
| Contingent consideration | ||||||||||||||||||||
| Right-of-use lease liabilities, current portion | ||||||||||||||||||||
| Term loan, current portion | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Noncurrent liabilities | ||||||||||||||||||||
| Term loan, net of discount and deferred financing fees | ||||||||||||||||||||
| Deferred tax liabilities, net | ||||||||||||||||||||
| Right-of-use lease liabilities, noncurrent portion | ||||||||||||||||||||
| Other noncurrent liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| 7% Series A Convertible Participating Preferred Stock, $0.01 par value; authorized shares at December 31, 2024 and 2023: 80,000; zero and 71,403 shares issued and outstanding; aggregate liquidation preference of zero and $492.6 million at December 31, 2024 and 2023, respectively | ||||||||||||||||||||
| Stockholders' equity | ||||||||||||||||||||
| Common stock, $0.01 par value; authorized shares at March 31, 2026 and December 31, 2025: 800,000; 197,909 and 197,697 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive (loss) income | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
